|

YL202 should be intravenously infused Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • MediLink Therapeutics (Suzhou) Co., Ltd.2

Indications

  • Breast Cancer2
  • Cancer2
  • Locally Advanced or Metastatic Solid Tumors1
  • HNSCC1
  • Locally Advanced or Metastatic Breast Cancer1

Other2 trials

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.